SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Xencor (XNCR)
An SI Board Since January 2014
Posts SubjectMarks Bans Symbol
136 22 0 XNCR
Emcee:  scaram(o)uche Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
36Amgen's BiTE® Immunotherapy Blinatumomab Receives FDA Priority Review Dscaram(o)uche-10/9/2014
35Ah, explains plenty...... sciencedaily.com I must be homozygous for all six vascaram(o)uche110/8/2014
34beer.... brewersassociation.orgscaram(o)uche-10/4/2014
33>> have to grant that there is some differentiation on the safety/efficacyscaram(o)uche19/16/2014
32Panther Biotech ticker PBYA just landed a potential blockbuster leukemia drug. XPUMATRADER-9/1/2014
31understood. thanks for the flag.mopgcw-8/26/2014
30Updated data from an ongoing trial, with further enrollment, hence a bit more rotuck-8/26/2014
29is this really new data??mopgcw-8/26/2014
28I guess we can add KITE to my list of competitive concerns for 5574. KITE CD19 tuck-8/26/2014
27I guess I'm more sanguine about the RA/autoimmune program; there seems to betuck-8/19/2014
26Well, 5574 is behind Blinatomomab, which sports pretty promising results to datetuck-8/18/2014
25Switched to Bloomberg, ages ago. So very sick of their closing hour hostess thascaram(o)uche18/12/2014
24Any specific concerns? Thanks.scaram(o)uche-8/12/2014
23Handy table from a MGNX patent published today..... TABLE 1 Receptors for thescaram(o)uche-8/12/2014
22Thoughts on how differentiated the non-asthma programs (RA & ALL programs) atuck-6/28/2014
21Well, Rick, you've persuaded me to start a position. :-) I even sold some PThe Dodgy Ticker-6/9/2014
20Again, thanks for starting this board and posting information. What impresses mgcrispin-6/9/2014
19I put this post up at IH, follow bouncing ball.... siliconinvestor.comscaram(o)uche-6/8/2014
18Hey, thanks for the thanks AND for the post. Yes, I'd say that the strengthscaram(o)uche-6/8/2014
17Also P2 for ALL results possibly by end of 2014. Thanks for highlighting this pfitzdad55-6/7/2014
16Morphosys at Jefferies... great update re. MOR208. Sounds like phase II NHL scaram(o)uche-6/5/2014
15MOR208 news..... finance.yahoo.comscaram(o)uche-5/20/2014
14Link works if you cut off the [/url] handle on the end. Thx for the pointer, AnBiotech Jim-4/17/2014
13>> confirms that the CSL anti-CD123 licensed by Janssen derives from a xncscaram(o)uche-4/17/2014
12I like this blog contribution, now up for a few days..... biotechvk.com And I scaram(o)uche-4/16/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News